Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT06200558
Brief Summary:
Study wants to explore real-world data in three distinct settings
* Patients with metachronous or de novo mCSPC treated with ADT+ARSI or ADT+ARSI+docetaxel \_ARON-3S
* Patients receiving Lutetium-177 PSMA for mCRPC \_ ARON-3Lu
* Patients treated with PARP inhibitors (alone or combined with ARSI) for CRPC \_ ARON-3GEN
Study:
NCT06200558
Study Brief:
Protocol Section:
NCT06200558